The principal activities of the Group are manufacture, sale, research and development of pharmaceutical products and health care products.
The Group have totally 17 GMP production lines which were granted GMP certification by the National Food and Drug Administration. There are one production line for each of large volume parenteral solution and small volume parenteral solution. The remaining 15 production lines are for products of different forms, namely pill, capsule, granule, powder, herbal tea, edible solution, syrup, suspension, nasal drop, eye drop, ear drop, tincture, solution, suppository and aerosol. The Group has permits for over 100 pharmaceutical products.
updated 14th May, 2008
| © Copyright 1996-2008 irasia.com Ltd. All rights reserved. |
|
DISCLAIMER: irasia.com Ltd makes no guarantee as to the accuracy or completeness of any
information provided on this website. Under no circumstances shall irasia.com Ltd be liable
for damages resulting from the use of the information provided on this website.
TRADEMARK & COPYRIGHT: All intellectual property rights subsisting in the contents of this website belong to irasia.com Ltd or have been lawfully licensed to irasia.com Ltd for use on this website. All rights under applicable laws are hereby reserved. Reproduction of this website in whole or in part without the express written permission of irasia.com Ltd is strictly prohibited. TERMS OF USE: Please read the Terms of Use governing the use of our website. |